Documentos relacionados

1. Upregulation of sulfatase-1 decreases metastatic potential of SKOV3 human ovarian cancer cells <i>in vitro</i> and <i>in vivo</i>.
2. 3D distribution of perlecan within intervertebral disc chondrons suggests novel regulatory roles for this multifunctional modular heparan sulphate proteoglycan.
3. Heparan sulfate proteoglycan molecules, syndecan and perlecan, have distinct roles in the maintenance of Drosophila germline stem cells.
4. Development of a new heparan sulfate proteoglycan (HSPG) chromolith LC column to study the pH dependence binding of peptide vaccines to HSPG and role of human serum albumin on its binding.
5. The role of the glypican and syndecan families of heparan sulfate proteoglycans in cardiovascular function and disease.
6. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
7. Heparan sulfate proteoglycans in cancer: Pathogenesis and therapeutic potential.
8. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.
9. Human diamine oxidase cellular binding and internalization in vitro and rapid clearance in vivo are not mediated by N-glycans but by heparan sulfate proteoglycan interactions.
10. Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion.